Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model


Brookdale Senior Living



) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.3%. By the end of trading, Brookdale Senior Living rose 44 cents (1.8%) to $24.90 on average volume. Throughout the day, 1.6 million shares of Brookdale Senior Living exchanged hands as compared to its average daily volume of 1.5 million shares. The stock ranged in a price between $24.39-$25.08 after having opened the day at $24.48 as compared to the previous trading day's close of $24.46. Other companies within the Health Care sector that increased today were:

ACADIA Pharmaceuticals



), up 136.1%,

Peregrine Pharmaceuticals



), up 26.8%,

Arrhythmia Research Technology



), up 23.1%, and




), up 19.4%.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. The company owns, leases, and operates retirement centers, assisted living and dementia-care communities, and continuing care retirement communities (CCRCs). Brookdale Senior Living has a market cap of $3.03 billion and is part of the health services industry. The company has a P/E ratio of -53.8, below the S&P 500 P/E ratio of 17.7. Shares are up 42.3% year to date as of the close of trading on Monday. Currently there are six analysts that rate Brookdale Senior Living a buy, no analysts rate it a sell, and one rates it a hold.

TheStreet Ratings rates Brookdale Senior Living as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and poor profit margins.

On the negative front,

Neptune Technologies & Bioressources



), down 24.5%,

Aoxing Pharmaceutical Company



), down 19.2%,




), down 9.3%, and

BG Medicine



), down 8.4%, were all laggards within the health care sector with

Intuitive Surgical



) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR



) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care




FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!